Biomarker Amplification by Serum Carrier Protein Binding

  • Mehta A
  • Ross S
  • Lowenthal M
  • et al.
N/ACitations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

Mass spectroscopic analysis of the low molecular mass (LMM) range of the serum/plasma proteome is a rapidly emerging frontier for biomarker discovery. This study examined the proportion of LMM biomarkers, which are bound to circulating carrier proteins. Mass spectroscopic analysis of human serum following molecular mass fractionation, demonstrated that the majority of LMM biomarkers exist bound to carrier proteins. Moreover, the pattern of LMM biomarkers bound specifically to albumin is distinct from those bound to non-albumin carriers. Prominent SELDI-TOF ionic species (m/z 6631.7043) identified to correlate with the presence of ovarian cancer were amplified by albumin capture. Several insights emerged: a) Accumulation of LMM biomarkers on circulating carrier proteins greatly amplifies the total serum/plasma concentration of the measurable biomarker, b) The total serum/plasma biomarker concentration is largely determined by the carrier protein clearance rate, not the unbound biomarker clearance rate itself, and c) Examination of the LMM species bound to a specific carrier protein may contain important diagnostic information. These findings shift the focus of biomarker detection to the carrier protein and its biomarker content.

Cite

CITATION STYLE

APA

Mehta, A. I., Ross, S., Lowenthal, M. S., Fusaro, V., Fishman, D. A., Petricoin, E. F., & Liotta, L. A. (2013). Biomarker Amplification by Serum Carrier Protein Binding. Disease Markers, 19(1), 1–10. https://doi.org/10.1155/2003/104879

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free